A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1089-1095

  Watanabe, Masami ^a,b   Sakaguchi, Masakiyo ^b   Kinoshita, Rie ^b   Kaku, Haruki ^a,b   Ariyoshi, Yuichi ^b   Ueki, Hideo ^b   Tanimoto, Ryuta ^b   Ebara, Shin ^b   Ochiai, Kazuhiko ^c   Futami, Junichiro ^b   Li, Shun Ai ^b   Huang, Peng ^b   Nasu, Yasutomo ^a,b   Huh, Nam Ho ^b   Kumon, Hiromi ^b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Adenovirus; Cytomegalovirus enhancer; Gene expression; Human telomerase reverse transcriptase enhancer; Simian virus 40 enhancer

Indexed keywords

ADENOVIRUS VECTOR; REDUCED EXPRESSION IN IMMORTALIZED CELL PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; ENHANCER REGION; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REDUCED EXPRESSION IN IMMORTALIZED CELL GENE; SINGLE DRUG DOSE; SUBCUTANEOUS TISSUE TUMOR; SUPER GENE EXPRESSION SYSTEM; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UPREGULATION; VALIDATION STUDY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; FEMALE; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; TUMOR BURDEN;

EID: 84896735946     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2958     Document Type: Article

References (24)

1. Nasu Y, Saika T, Ebara S, Kusaka N, Kaku H, Abarzua F, Manabe D, Thompson TC and Kumon H: Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther 15: 834-840, 2007. (Pubitemid 46432005)
2. Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML and Naomoto Y: Adenovirus-mediated cancer gene therapy and virotherapy (Review). Int J Mol Med 25: 3-10, 2010.
3. Niwa H, Yamamura K and Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199, 1991.
4. Araki K, Araki M, Miyazaki J and Vassalli P: Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 92: 160-164, 1995.
5. Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E and Thompson TC: Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Prostate Cancer Prostatic Dis 5: 316-325, 2002. (Pubitemid 36124444)
6. Watanabe M, Nasu Y, Kashiwakura Y, Kusumi N, Tamayose K, Nagai A, Sasano T, Shimada T, Daida H and Kumon H: Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. Hum Gene Ther 16: 699-710, 2005. (Pubitemid 40864270)
7. Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T and Hayakawa T: Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 272: 149-156, 2001. (Pubitemid 32695407)
8. Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T and Hayakawa T: Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. J Control Release 81: 155-163, 2002. (Pubitemid 34454857)
9. Young JL, Benoit JN and Dean DA: Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Ther 10: 1465-1470, 2003. (Pubitemid 36987140)
10. Song JS: Enhanced expression of apoptin by the Myc-Max binding motif and SV40 enhancer for SCLC gene therapy. Biosci Biotechnol Biochem 69: 51-55, 2005.
11. Kim SJ, Lee HS, Shin JH, Kim CG, Jeong S, Park K, Choe H and Lee H: Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells. Oncol Rep 16: 975-979, 2006.
12. Kojima T, Hashimoto Y, Watanabe Y, Kagawa S, Uno F, Kuroda S, Tazawa H, Kyo S, Mizuguchi H, Urata Y, Tanaka N and Fujiwara T: A simple biological imaging system for detecting viable human circulating tumor cells. J Clin Invest 119: 3172-3181, 2009.
13. Watanabe M, Ueki H, Ochiai K, Huang P, Kobayashi Y, Nasu Y, Sasaki K, Kaku H, Kashiwakura Y and Kumon H: Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging. Oncol Rep 26: 769-775, 2011.
14. Ueki H, Watanabe M, Kaku H, Huang P, Li SA, Ochiai K, Hirata T, Noguchi H, Yamada H, Takei K, Nasu Y, Kashiwakura Y and Kumon H: A novel gene expression system for detecting viable bladder cancer cells. Int J Oncol 41: 135-140, 2012.
15. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y and Namba M: A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20-24, 2000. (Pubitemid 30116603)
16. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH: Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617-9622, 2005. (Pubitemid 41541434)
17. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and Kumon H: Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res 68: 8333-8341, 2008.
18. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H and Date H: REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 16: 65-72, 2009.
19. Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 34: 657-663, 2009.
20. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y, Ochiai K, Nasu Y, Kumon H and Huh NH: Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 284: 14236-14244, 2009.
21. Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M, Ochiai K, Yamada H, Takei K, Ueki H, Huh NH, Li M, Kaku H, Na Y and Kumon H: Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol 37: 1495-1501, 2010.
22. Ochiai K, Watanabe M, Ueki H, Huang P, Fujii Y, Nasu Y, Noguchi H, Hirata T, Sakaguchi M, Huh NH, Kashiwakura Y, Kaku H and Kumon H: Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochem Biophys Res Commun 412: 391-395, 2011.
23. Hirata T, Watanabe M, Kaku H, Kobayashi Y, Yamada H, Sakaguchi M, Takei K, Huh NH, Nasu Y and Kumon H: REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. Int J Oncol 41: 559-564, 2012.
24. Wang CY, Guo HY, Lim TM, Ng YK, Neo HP, Hwang PY, Yee WC and Wang S: Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter. J Gene Med 7: 945-955, 2005. (Pubitemid 41015543)